English  |  正體中文  |  简体中文  |  总笔数 :2823698  
造访人次 :  30511284    在线人数 :  1127
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"liao w y"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 26-50 / 352 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-06-27T07:00:21Z Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases Lin C.-H.; Hsieh S.-C.; Keng L.-T.; Lee H.-S.; Chang H.-T.; Liao W.-Y.; Ho C.-C.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:00:19Z The unmet supportive care needs—what advanced lung cancer patients’ caregivers need and related factors Chen S.-C.; Chiou S.-C.; CHONG-JEN YU; Lee Y.-H.; Liao W.-Y.; Hsieh P.-Y.; Jhang S.-Y.; Lai Y.-H.
臺大學術典藏 2022-06-27T07:00:12Z Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study Chang G.-C.; Tseng C.-H.; Hsu K.-H.; CHONG-JEN YU; Yang C.-T.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Liu C.-Y.; Liao W.-Y.; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; Tsai Y.-H.; Hsieh M.-J.; Wu W.-S.; Chen Y.-M.
臺大學術典藏 2022-06-27T07:00:11Z Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib Ho C.-C.; Liao W.-Y.; Lin C.-A.; Shih J.-Y.; CHONG-JEN YU; Chih-Hsin Yang J.
臺大學術典藏 2022-06-27T07:00:07Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:00:05Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:00:04Z Cigarette smoke extract enhances the invasion of lung cancer cells co-cultured with fibroblasts in 3D cellular spheroids Pan H.-J.; Hou H.-H.; Hung Y.-C.; Liao W.-Y.; CHONG-JEN YU; Lee C.-H.
臺大學術典藏 2022-06-27T07:00:04Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; CHONG-JEN YU; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.
臺大學術典藏 2022-06-27T07:00:03Z Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study Liao Y.-C.; Liao W.-Y.; Sun J.-L.; Ko J.-C.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:00:03Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏 2022-06-27T07:00:01Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Liao W.-Y.; Ho C.-C.; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:00:01Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; CHONG-JEN YU; Yang J.C.-H.
臺大學術典藏 2022-06-27T07:00:00Z Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer Lee Y.-H.; Liao Y.-C.; Shun S.-C.; Lin K.-C.; Liao W.-Y.; Chang P.-H.; Jhang S.-Y.; CHONG-JEN YU; Yang P.-C.; Hsieh P.-Y.; Lai Y.-H.
臺大學術典藏 2022-06-27T06:59:55Z Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:53Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:51Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:49Z Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H.
臺大學術典藏 2022-06-27T06:59:47Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:43Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:40Z Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells Hou H.-H.; Pan H.-J.; Liao W.-Y.; Lee C.-H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:38Z Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H.
臺大學術典藏 2022-06-27T06:59:37Z Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; CHONG-JEN YU; Chih-Hsin Yang J.; Shih J.-Y.
臺大學術典藏 2022-06-10T06:11:00Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; ZHONG-ZHE LIN; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏 2022-06-10T06:10:58Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; ZHONG-ZHE LIN; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-06-10T06:10:57Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; ZHONG-ZHE LIN; Lin C.-C.; Yang J.C.-H.; Yu C.-J.

显示项目 26-50 / 352 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目